BamSEC and AlphaSense Join Forces
Learn More

Prime Medicine Inc. – Material Contracts

NASDAQ: PRME    
Share price (11/17/26): $3.84    
Market cap (11/17/26): $699 million

Material Contracts Filter

EX-10.1
from 10-Q 2 pages Prime Medicine, Inc. Third Amended and Restated Non-Employee Director Compensation Policy
12/34/56
EX-10.1
from 8-K 12 pages Employment Agreement
12/34/56
EX-10.3
from 10-Q 4 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Information That Was Omitted Has Been Noted in This Document With a Placeholder Identified by the Mark “[***]”. September 11, 2025 the Broad Institute, Inc. 415 Main Street Cambridge, Ma 02142 Attn: Michael Christiano, Chief Business Officer Re: License Agreement, by and Between the Broad Institute, Inc. and Prime Medicine, Inc., Dated September 26, 2019 Dear Michael,
12/34/56
EX-10.2
from 10-Q 5 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Information That Was Omitted Has Been Noted in This Document With a Placeholder Identified by the Mark “[***]”. Fifth Amendment to License Agreement
12/34/56
EX-10.1
from 10-Q 3 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Information That Was Omitted Has Been Noted in This Document With a Placeholder Identified by the Mark “[***]”. Fourth Amendment to License Agreement
12/34/56
EX-10.6
from 10-Q 8 pages Consulting Agreement
12/34/56
EX-10.5
from 10-Q 13 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Information That Was Omitted Has Been Noted in This Document With a Placeholder Identified by the Mark “[***]”. July 17, 2025 Personal and Confidential Jeremy Duffield, M.D. PH.D., Frcp [***] Dear Jeremy: Re: Separation Agreement
12/34/56
EX-10.4
from 10-Q 16 pages Amended and Restated Employment Agreement
12/34/56
EX-10.3
from 10-Q 9 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Information That Was Omitted Has Been Noted in This Document With a Placeholder Identified by the Mark “[***]”. Consulting Agreement
12/34/56
EX-10.2
from 10-Q 11 pages Separation Agreement
12/34/56
EX-10.1
from 10-Q 3 pages Prime Medicine, Inc. Second Amended and Restated Non-Employee Director Compensation Policy
12/34/56
EX-10.3
from 10-Q 8 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Information That Was Omitted Has Been Noted in This Document With a Placeholder Identified by the Mark “[***]”
12/34/56
EX-10.2
from 10-Q 86 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Information That Was Omitted Has Been Noted in This Document With a Placeholder Identified by the Mark “[***]”. Research Collaboration and License Agreement Dated as of September 28, 2024 by and Between Prime Medicine, Inc. and Juno Therapeutics, Inc
12/34/56
EX-10.1
from 10-Q 45 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Information That Was Omitted Has Been Noted in This Document With a Placeholder Identified by the Mark “[***]”. Prime Medicine, Inc. Securities Purchase Agreement
12/34/56
EX-10.1
from 10-Q 3 pages Prime Medicine, Inc. Amended and Restated Non-Employee Director Compensation Policy
12/34/56
EX-10.22
from 10-K 3 pages Twelfth Amendment to License Agreement
12/34/56
EX-10.1
from 8-K 12 pages Employment Agreement
12/34/56
EX-10.1
from 10-Q 2 pages Amendment No. 1 to Employment Agreement
12/34/56
EX-10.5
from 10-Q 2 pages Eleventh Amendment to License Agreement
12/34/56
EX-10.4
from 10-Q 3 pages Tenth Amendment to License Agreement
12/34/56